Literature DB >> 114107

Activity of beta-lactam antibiotics against Pseudomonas aeruginosa carrying R plasmids determining different beta-lactamases.

G A Jacoby, L Sutton.   

Abstract

Azlocillin, carbenicillin, cefsulodin, mezlocillin, nocardicin A, piperacillin, pirbenicillin, sulbenicillin, and ticarcillin, but not HR756, showed reduced activity against Pseudomonas aeruginosa strains producing seven types of beta-lactamase.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 114107      PMCID: PMC352832          DOI: 10.1128/AAC.16.2.243

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Analytical isoelectric focusing of R factor-determined beta-lactamases: correlation with plasmid compatibility.

Authors:  M Matthew; R W Hedges
Journal:  J Bacteriol       Date:  1976-02       Impact factor: 3.490

2.  Plasmid-mediated penicillin beta-lactamases in Pseudomonas aeruginosa.

Authors:  Y Sawada; S Yaginuma; M Tai; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

3.  beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

4.  Acquisition by Escherichia coli of plasmid-borne beta-lactamases normally confined to Pseudomonas spp.

Authors:  R W Hedges; M Matthew
Journal:  Plasmid       Date:  1979-04       Impact factor: 3.466

5.  R factors, beta-lactamase, and carbenicillin-resistant Pseudomonas aeruginosa.

Authors:  R B Sykes; M H Richmond
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

6.  Properties of the beta-lactamase specified by the Pseudomonas plasmid RPL11.

Authors:  M Matthew; R B Sykes
Journal:  J Bacteriol       Date:  1977-10       Impact factor: 3.490

7.  Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin.

Authors:  E J Lowbury; H A Lilly; A Kidson; G A Ayliffe; R J Jones
Journal:  Lancet       Date:  1969-08-30       Impact factor: 79.321

8.  Properties of R plasmids determining gentamicin resistance by acetylation in Pseudomonas aeruginosa.

Authors:  G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

9.  Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.

Authors:  H C Neu; G J Garvey
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

10.  SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities.

Authors:  K Tsuchiya; M Kondo; H Nagatomo
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

View more
  11 in total

1.  Physiological studies of the regulation of beta-lactamase expression in Pseudomonas maltophilia.

Authors:  S Rosta; H Mett
Journal:  J Bacteriol       Date:  1989-01       Impact factor: 3.490

2.  Rapid method for determining the beta-lactamase-inducing potency of drugs.

Authors:  H Mett; I Oberkirch; B Schacher
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

Review 3.  Mechanisms of resistance to cephalosporin antibiotics.

Authors:  D M Livermore
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  In vitro activities of ICI 194008 and ICI 193428, two new cephem antimicrobial agents.

Authors:  J D Allan; G M Eliopoulos; E Reiszner; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

5.  A TEM-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa.

Authors:  P Mugnier; P Dubrous; I Casin; G Arlet; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

6.  In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolates.

Authors:  G M Eliopoulos; A Gardella; P DeGirolami; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

7.  Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.

Authors:  A Thabaut; J L Durosoir; P Saliou
Journal:  Infection       Date:  1982       Impact factor: 3.553

8.  In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic.

Authors:  A Imada; M Kondo; K Okonogi; K Yukishige; M Kuno
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

9.  Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa.

Authors:  S B Calderwood; A Gardella; A M Philippon; G A Jacoby; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  beta-Lactamases and beta-lactam resistance in Escherichia coli.

Authors:  G A Jacoby; L Sutton
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.